Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaseron vs Avonex in RRMS (ABOVE)
NCT00206648Phase 4Completed
- Sponsor
- Bayer
- Start
- Mar 2003
- Modality
- Interferons
- Countries
- 2
01
Overview
A Phase 4 trial of interferon beta in relapsing-remitting multiple sclerosis (RRMS), sponsored by Bayer. Started Mar 2003; status: completed.
02
Drugs
interferon beta
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00206648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206648.